Depression

Meta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressants.
[18832497] Psychiatr Serv 59(10): 1121-30 (2008)

A review of pharmacotherapy of major depression in children and adolescents.
[10783181] Psychiatr Serv 51(5): 627-33 (2000)

A systematic review of the mortality of depression.
[10024062] Psychosom Med 61(1): 6-17 (1999)

Status of treatment of depression.
[10498158] South Med J 92(9): 846-56 (1999)

The neuroendocrinology of depression and chronic stress.
[8949260] Br Med Bull 52(3): 597-617 (1996)

Clinical guidelines for depressive disorders. Summary of recommendations relevant to family physicians.
[12729245] Can Fam Physician 49(-): 489-91 (2003)

Adolescent depression. Part 2. Treatment.
[7920052] Can Fam Physician 40(-): 1591-4, 1597-8 (1994)

Adolescent depression. Part 1. Diagnosis.
[7920051] Can Fam Physician 40(-): 1583-7 (1994)

Treatment of depressive disorders.
[19578410] Dtsch Arztebl Int 105(45): 782-92 (2008)

Depression in children and adolescents.
[19633781] Dtsch Arztebl Int 105(9): 149-55 (2008)

The homocysteine hypothesis of depression.
[17541043] Am J Psychiatry 164(6): 861-7 (2007)

The prevention of depression in children and adolescents: a review.
[19321027] Can J Psychiatry 54(4): 212-21 (2009)

Metareview on short-term effectiveness and safety of antidepressants for depression: an evidence-based approach to inform clinical practice.
[17953159] Can J Psychiatry 52(9): 553-62 (2007)

Long-term treatment of depression with antidepressants: a systematic narrative review.
[17953158] Can J Psychiatry 52(9): 545-52 (2007)

Major depressive disorder in adolescence: a brief review of the recent treatment literature.
[14631880] Can J Psychiatry 48(9): 600-6 (2003)

Lithium augmentation therapy in refractory depression: clinical evidence and neurobiological mechanisms.
[12971013] Can J Psychiatry 48(7): 440-8 (2003)

Clinical guidelines for the treatment of depressive disorders, I. Definitions, prevalence, and health burden.
[11441768] Can J Psychiatry 46 Suppl 1(-): 13S-20S (2001)

Clinical guidelines for the treatment of depressive disorders. II. Principles of management.
[11441769] Can J Psychiatry 46 Suppl 1(-): 21S-28S (2001)

Clinical guidelines for the treatment of depressive disorders. III. Psychotherapy.
[11441770] Can J Psychiatry 46 Suppl 1(-): 29S-37S (2001)

Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments.
[11441771] Can J Psychiatry 46 Suppl 1(-): 38S-58S (2001)

Clinical guidelines for the treatment of depressive disorders. V. Combining psychotherapy and pharmacotherapy.
[11441772] Can J Psychiatry 46 Suppl 1(-): 59S-62S (2001)

Clinical guidelines for the treatment of depressive disorders. VI. Special populations.
[11441773] Can J Psychiatry 46 Suppl 1(-): 63S-76S (2001)

Clinical guidelines for the treatment of depressive disorders. VII. Comorbidity.
[11441774] Can J Psychiatry 46 Suppl 1(-): 77S-90S (2001)

Systematic review of lithium augmentation in depression resistant to at least 2 antidepressants.
[19750072] Prim Care Companion J Clin Psychiatry 11(4): 172 (2009)

Translating Science Into Service: Lessons Learned From the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study.
[17998951] Prim Care Companion J Clin Psychiatry 9(5): 331-7 (2007)

Use of treatment algorithms for depression.
[17235386] Prim Care Companion J Clin Psychiatry 8(5): 291-8 (2006)

Persisting decline in depression treatment after FDA warnings.
[19487628] Arch Gen Psychiatry 66(6): 633-9 (2009)

Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis.
[17088502] Arch Gen Psychiatry 63(11): 1217-23 (2006)

Combined pharmacotherapy and psychological treatment for depression: a systematic review.
[15237083] Arch Gen Psychiatry 61(7): 714-9 (2004)

Algorithms for the pharmacotherapy of major depression.
[10560904] Psychiatry Clin Neurosci 53 Suppl(-): S77-82 (1999)

Amygdala volume in major depressive disorder: a meta-analysis of magnetic resonance imaging studies.
[18504424] Mol Psychiatry 13(11): 993-1000 (2008)

A review of quetiapine in combination with antidepressant therapy in patients with depression.
[19300621] Neuropsychiatr Dis Treat 3(6): 855-67 (2007)

Onset of improvement and response to mirtazapine in depression: a multicenter naturalistic study of 4771 patients.
[18568129] Neuropsychiatr Dis Treat 1(1): 59-68 (2005)

Neurobiology of depression.
[11931738] Neuron 34(1): 13-25 (2002)

Major depressive disorder.
[11144343] Neuron 28(2): 335-41 (2000)

Treatment strategies to improve and sustain remission in major depressive disorder.
[19170395] Dialogues Clin Neurosci 10(4): 377-84 (2008)

Towards achieving remission in the treatment of depression.
[19170394] Dialogues Clin Neurosci 10(4): 371-5 (2008)

Diurnal variation of depressive symptoms.
[18979947] Dialogues Clin Neurosci 10(3): 337-43 (2008)

Towards a scientific taxonomy of depression.
[18979943] Dialogues Clin Neurosci 10(3): 301-8 (2008)

Core symptoms of major depressive disorder: relevance to diagnosis and treatment.
[18979940] Dialogues Clin Neurosci 10(3): 271-7 (2008)

Experimental animal models for the simulation of depression and anxiety.
[17117614] Dialogues Clin Neurosci 8(3): 323-33 (2006)

Depression and associated physical diseases and symptoms.
[16889110] Dialogues Clin Neurosci 8(2): 259-65 (2006)

Nonpharmacological, somatic treatments of depression: electroconvulsive therapy and novel brain stimulation modalities.
[16889109] Dialogues Clin Neurosci 8(2): 241-58 (2006)

Somatic symptoms in depression.
[16889108] Dialogues Clin Neurosci 8(2): 227-39 (2006)

Depression and sleep: pathophysiology and treatment.
[16889107] Dialogues Clin Neurosci 8(2): 217-26 (2006)

Future prospects in depression research.
[16889104] Dialogues Clin Neurosci 8(2): 175-89 (2006)

Neuroendocrine predictors of the evolution of depression.
[16156385] Dialogues Clin Neurosci 7(3): 273-82 (2005)

The pharmacological management of depression.
[16156378] Dialogues Clin Neurosci 7(3): 191-205 (2005)

The role of L-methylfolate in depressive disorders.
[19169195] CNS Spectr 14(1 Suppl 2): 2-7 (2009)

Improving the prediction of treatment response in depression: integration of clinical, cognitive, psychophysiological, neuroimaging, and genetic measures.
[19179943] CNS Spectr 13(12): 1066-86; quiz 1087-8 (2008)

The future of depression psychopharmacology.
[18704023] CNS Spectr 13(8): 682-7 (2008)

Inflammation, glutamate, and glia in depression: a literature review.
[18567974] CNS Spectr 13(6): 501-10 (2008)

Augmentation strategies in the treatment of major depressive disorder. Examining the evidence on augmentation with atypical antipsychotics.
[18396509] CNS Spectr 12(12 Suppl 22): 10-2 (2007)

Augmentation strategies in the treatment of major depressive disorder. Recent findings and current status of augmentation strategies.
[18396508] CNS Spectr 12(12 Suppl 22): 6-9 (2007)

Augmentation strategies for depression: history and concepts.
[18396507] CNS Spectr 12(12 Suppl 22): 3-5 (2007)

Novel therapeutics for depression: L-methylfolate as a trimonoamine modulator and antidepressant-augmenting agent.
[17934378] CNS Spectr 12(10): 739-44 (2007)

Consensus recommendations for improving adherence, self-management, and outcomes in patients with depression.
[17986951] CNS Spectr 12(8 Suppl 13): 1-27 (2007)

Clinical assessment of suicide risk in depressive disorder.
[16816777] CNS Spectr 11(6): 455-61 (2006)

Lamotrigine augmentation strategy for patients with treatment-resistant depression.
[16400242] CNS Spectr 10(10): 800-5 (2005)

Therapeutic alternatives for difficult-to-treat depression: a narrative review of the state of the evidence.
[15520605] CNS Spectr 9(11): 808-16, 818-21 (2004)

Agomelatine: The evidence for its place in the treatment of depression.
[20694073] Core Evid 4(-): 171-9 (2010)

Desvenlafaxine in major depressive disorder: an evidence-based review of its place in therapy.
[20694066] Core Evid 4(-): 67-82 (2010)

The molecular neurobiology of depression.
[18923511] Nature 455(7215): 894-902 (2008)

Potential surgical targets for deep brain stimulation in treatment-resistant depression.
[18590380] Neurosurg Focus 25(1): E3 (2008)

Biological basis for the surgical treatment of depression.
[18590379] Neurosurg Focus 25(1): E2 (2008)

Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder.
[16172440] Ann Intern Med 143(6): 415-26 (2005)

Magnetic resonance imaging and prediction of outcome in patients with major depressive disorder.
[19721844] J Psychiatry Neurosci 34(5): 343-9 (2009)

Implications of adult hippocampal neurogenesis in antidepressant action.
[15173896] J Psychiatry Neurosci 29(3): 196-205 (2004)

Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression.
[15173895] J Psychiatry Neurosci 29(3): 185-93 (2004)

Crosstalk between the norepinephrine and serotonin systems and its role in the antidepressant response.
[11590967] J Psychiatry Neurosci 26 Suppl(-): S3-10 (2001)

Refractory depression: treatment strategies, with particular reference to the thyroid axis.
[9401313] J Psychiatry Neurosci 22(5): 327-31 (1997)

Can drugs cause depression? A review of the evidence.
[8499431] J Psychiatry Neurosci 18(3): 92-102 (1993)

Effects of adrenal cortex hormones on limbic structures: some experimental and clinical correlations related to depression.
[8461280] J Psychiatry Neurosci 18(1): 4-16 (1993)

Neurostimulatory and ablative treatment options in major depressive disorder: a systematic review.
[20101419] Acta Neurochir (Wien) 152(4): 565-77 (2010)

Treatment of depressed adolescents.
[20595423] Am J Psychiatry 167(7): 734-7 (2010)

What have we learned about the neurobiology of major depression?
[17403962] Am J Psychiatry 164(4): 540-2 (2007)

The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence.
[15800134] Am J Psychiatry 162(4): 656-62 (2005)

Perimenopausal depression.
[18178752] Am J Psychiatry 165(1): 23-7 (2008)

Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials.
[20940209] BMJ 341(-): c4737 (2010)

Management of depression in adults.
[18292169] BMJ 336(7641): 435-9 (2008)

Use of deep brain stimulation in treatment-resistant depression.
[20622083] Cleve Clin J Med 77 Suppl 3(-): S77-80 (2010)

Accuracy of depression screening tools for identifying postpartum depression among urban mothers.
[20156899] Pediatrics 125(3): e609-17 (2010)

A generalist's guide to treating patients with depression with an emphasis on using side effects to tailor antidepressant therapy.
[20431115] Mayo Clin Proc 85(6): 538-50 (2010)

Citalopram for major depressive disorder in adults: a systematic review and meta-analysis of published placebo-controlled trials.
[22021869] BMJ Open 1(2): e000106 (2011)

New therapeutic targets for mood disorders.
[20419280] ScientificWorldJournal 10(-): 713-26 (2010)

A systematic review and economic evaluation of computerised cognitive behaviour therapy for depression and anxiety.
[12433315] Health Technol Assess 6(22): 1-89 (2002)

Strategies to enhance the therapeutic efficacy of antidepressants: targeting residual symptoms.
[19589048] Expert Rev Neurother 9(7): 975-84 (2009)

Neurobiology of depression, fibromyalgia and neuropathic pain.
[19482616] Front Biosci 14(-): 5291-338 (2009)

Neurobiological aspects of depressive disorder and antidepressant treatment: role of glia.
[17465696] Physiol Res 57(2): 151-64 (2008)

First-line pharmacotherapies for depression - what is the best choice?
[19776688] Pol Arch Med Wewn 119(7-8): 478-86 (2009)

The leptin hypothesis of depression: a potential link between mood disorders and obesity?
[18032111] Curr Opin Pharmacol 7(6): 648-52 (2007)

Stress-induced dendritic remodeling in the medial prefrontal cortex: effects of circuit, hormones and rest.
[19361488] Brain Res 1293(-): 108-13 (2009)

Continuation treatment of major depressive disorder: is there a case for duloxetine?
[20368904] Drug Des Devel Ther 4(-): 19-31 (2010)

Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms.
[18784657] Nat Rev Neurosci 9(10): 788-96 (2008)

Comparative efficacy of escitalopram in the treatment of major depressive disorder.
[21430793] Neuropsychiatr Dis Treat 7(-): 39-49 (2011)

A review of etiologies of depression in COPD.
[18268923] Int J Chron Obstruct Pulmon Dis 2(4): 485-91 (2007)

Treatment for depression after traumatic brain injury: a systematic review.
[19698070] J Neurotrauma 26(12): 2383-402 (2009)

A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation.
[21358978] Curr Neuropharmacol 8(3): 287-304 (2010)

Neurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodents.
[18654637] Curr Neuropharmacol 4(4): 277-91 (2006)

Transcranial magnetic stimulation: a new tool in the fight against depression.
[22033886] Dialogues Clin Neurosci 4(1): 93-103 (2002)

Neurobiological mechanisms of repetitive transcranial magnetic stimulation on the underlying neurocircuitry in unipolar depression.
[21485753] Dialogues Clin Neurosci 13(1): 139-45 (2011)

Depressogenic effects of medications: a review.
[21485751] Dialogues Clin Neurosci 13(1): 109-25 (2011)

Hormone treatment of depression.
[21485752] Dialogues Clin Neurosci 13(1): 127-38 (2011)

Discovering endophenotypes for major depression.
[15213704] Neuropsychopharmacology 29(10): 1765-81 (2004)

Neurocircuitry of mood disorders.
[19693001] Neuropsychopharmacology 35(1): 192-216 (2010)

VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms.
[16641939] Neuropsychopharmacology 31(7): 1345-55 (2006)

Black sheep get the blues: a psychobiological model of social rejection and depression.
[20083138] Neurosci Biobehav Rev 35(1): 39-45 (2010)

A critical review of human endotoxin administration as an experimental paradigm of depression.
[19666048] Neurosci Biobehav Rev 34(1): 130-43 (2010)

Enhancement of endocannabinoid signaling and the pharmacotherapy of depression.
[17945507] Pharmacol Res 56(5): 360-6 (2007)

Pharmacologic approaches to treatment resistant depression: a re-examination for the modern era.
[20151847] Expert Opin Pharmacother 11(5): 709-22 (2010)

Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder.
[20406250] CNS Neurosci Ther 16(3): e1-17 (2010)

Lithium's emerging role in the treatment of refractory major depressive episodes: augmentation of antidepressants.
[20453533] Neuropsychobiology 62(1): 36-42 (2010)

Serotonin-1A receptor imaging in recurrent depression: replication and literature review.
[17921037] Nucl Med Biol 34(7): 865-77 (2007)

In search of HPA axis dysregulation in child and adolescent depression.
[21290178] Clin Child Fam Psychol Rev 14(2): 135-60 (2011)

Disruption of circadian rhythms: a crucial factor in the etiology of depression.
[21845223] Depress Res Treat 2011(-): 839743 (2011)

Review: magnetic resonance spectroscopy studies of pediatric major depressive disorder.
[21197097] Depress Res Treat 2011(-): 650450 (2011)

Escitalopram--translating molecular properties into clinical benefit: reviewing the evidence in major depression.
[20147575] J Psychopharmacol 24(8): 1143-52 (2010)

Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies.
[19944762] Neurobiol Dis 37(3): 519-33 (2010)

The genetics of major depression: moving beyond the monoamine hypothesis.
[20159343] Psychiatr Clin North Am 33(1): 125-40 (2010)

The molecular neurobiology of depression.
[17362799] Psychiatr Clin North Am 30(1): 1-11 (2007)

How to increase serotonin in the human brain without drugs.
[18043762] J Psychiatry Neurosci 32(6): 394-9 (2007)

From synapse to nucleus: novel targets for treating depression.
[20018197] Neuropharmacology 58(4-5): 683-93 (2010)

Beyond monoamines: glutamatergic function in mood disorders.
[16400244] CNS Spectr 10(10): 808-19 (2005)

Depression research: where are we now?
[20219105] Mol Brain 3(-): 8 (2010)

Interoception in anxiety and depression.
[20490545] Brain Struct Funct 214(5-6): 451-63 (2010)

Gliogenesis and glial pathology in depression.
[17511618] CNS Neurol Disord Drug Targets 6(3): 219-33 (2007)

The bright side of being blue: depression as an adaptation for analyzing complex problems.
[19618990] Psychol Rev 116(3): 620-54 (2009)

The functional neuroanatomy of depression: distinct roles for ventromedial and dorsolateral prefrontal cortex.
[19428640] Behav Brain Res 201(2): 239-43 (2009)

Meta-review of the effectiveness of computerised CBT in treating depression.
[21838902] BMC Psychiatry 11(-): 131 (2011)

Social neuroscience of child and adolescent depression.
[17624647] Brain Cogn 65(1): 47-68 (2007)

SSRIs and SNRIs: A review of the Discontinuation Syndrome in Children and Adolescents.
[21286371] J Can Acad Child Adolesc Psychiatry 20(1): 60-7 (2011)

Pharmaceutical treatment of acute bipolar depression.
[20948837] F1000 Med Rep 2(-): - (2010)

Localization of dysfunction in major depressive disorder: prefrontal cortex and amygdala.
[21111403] Biol Psychiatry 69(12): e43-54 (2011)

Deep brain stimulation for treatment-resistant depression.
[21131410] Am J Psychiatry 167(12): 1437-44 (2010)

The emerging role for repetitive transcranial magnetic stimulation in optimizing the treatment of adolescent depression.
[20418774] J ECT 26(4): 323-9 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Depression.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Depression.php on line 92